-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Amylyx Pharmaceuticals, Raises Price Target to $39

Benzinga·10/15/2026 16:53:49
語音播報
Citigroup analyst Geoff Meacham maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Buy and raises the price target from $32 to $39.